-
First Arab Middle Eastern Genetics Research in Autism Going Global Thanks to Qatar’s Sidra Medicine, we now have a better understanding of Middle Eastern Genetics and their Implications for ASD 1 April 2024, Doha, Qatar – On World Autism Awarene… Continue Reading.....
-
Sidra Medicine Appoints Wouter Van den Brande as New Chief Operating Officer 12 March 2024, Doha, Qatar – Sidra Medicine has appointed Mr. Wouter Van den Brande as its new Chief Operating Officer (COO). As COO of Sidra Medicine, Wouter's responsibilities will include overse… Continue Reading.....
-
Sidra Medicine Empowers Rare Disease Research QF Entity opens accessibility to state-of-the-art research services 28 February 2024, Doha, Qatar – In support of Rare Disease Day, Sidra Medicine today announced the accessibility of its unique an… Continue Reading.....
-
Sidra Medicine and Msheireb Museums Launch Science Café Series QF Entities to bring science to the community 26 February 2024, Doha, Qatar – Sidra Medicine and Msheireb Museums, members of Qatar Foundation, are launching their first Science Café series. The… Continue Reading.....
-
Sidra Medicine Expands ENT Services QF Entity performs first pediatric vocal cord injection medialization procedure 06 February 2024, Doha, Qatar –Sidra Medicine, a member of Qatar Foundation, has expanded its pediatric Oto… Continue Reading.....
-
Sidra Medicine Pioneers New Pediatric Treatment Protocol for Infant with Congenital Hyperinsulinism 28 January 2024, Doha, Qatar – In a world first, Sidra Medicine, a member of Qatar Foundation, has pioneered a new treatment protocol for a young infant with congenital hyperinsulinism. The findings h… Continue Reading.....